(3) Area IIP. Area IIP includes Cambodia, Laos, and Vietnam.
Immunizations required of all persons subject to this regulation traveling through or
residing in Area IIP are those for Area II, plus plague.
(4) Area IIY. Area IIY includes Central America southeast of the Istmus of
Tehuantepec, Panama, South America, and Africa south of the Sahara. Immunizations
required of all persons subject to this regulation traveling through or residing in Area IIY
are those for Area II plus yellow fever. Yellow fever immunization is also required for
travel from Area IIY to yellow fever receptive areas, as indicated on figure 2-1, with the
exception of the US.
Special immunizations are those that are administered selectively to certain
categories of persons or in the event of unusual circumstances. The following
immunizations are administered by the Army on a selective basis.
a. Adenovirus Vaccine and Meningococcal Vaccine. The Surgeon General
of the Army has the sole authority to direct the use of these two vaccines. They are
administered only to basic trainees (includes recruits, inductees, and all others without
prior service), who, as a group, make up the vast majority of cases of these two
b. Measles Vaccine. Measles vaccine is recommended for children age 1
through 14 years who have not had natural measles.
c. Rubella Vaccine. Rubella (German measles) vaccine is recommended for
children age 1 through 14 who have not had natural rubella (German measles).
d. Diphtheria and Tetanus Toxoids and Pertussis Vaccine, Absorbed.
Diphtheria and Tetanus Toxoids and Pertussis Vaccine, Absorbed (DPT) is
recommended for children from 2-3 months through 6 years of age.
e. Mumps Vaccine. This vaccine is recommended for use only during
outbreaks of mumps, to be administered to all persons age 12 months or older who
have not had natural mumps. It is of particular value in children approaching puberty, in
adolescents, and in adults, especially males.
f. Tetanus Immune Globulin (Human) and Tetanus Antitoxin. When the
status of previous immunization is such that there is no assurance of circulating
antibody at the time an injury occurs, passive protection must be provided by the use of
tetanus immune globulin (human). Tetanus antitoxin (from horse serum) is used only
when tetanus immune globulin is not available.